Safety and Effectiveness of Cardiac Resynchronization Therapy With Defibrillation
NCT ID: NCT00387803
Last Updated: 2007-01-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
581 participants
INTERVENTIONAL
1998-02-28
2001-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure
NCT00180258
Ensure Cardiac Resynchronization Therapy Study
NCT00291564
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial
NCT00251251
A Pilot Study of Interventricular Septal Puncture for Cardiac Resynchronization Therapy to Treat Heart Failure
NCT01818765
Optimizing Cardiac Resynchronization
NCT00205192
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiac Resynchronization Therapy with Defibrillation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Left ventricular ejection fraction \<= 35%
* QRS width \>= 120 ms
* Indicated for an implantable cardioverter defibrillator
Exclusion Criteria
* Atrial tachyarrhythmias
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston Scientific Corporation
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Steven Higgins, MD
Role: PRINCIPAL_INVESTIGATOR
Scripps Memorial Hospital
Leslie A Saxon, MD
Role: PRINCIPAL_INVESTIGATOR
University of California San Francisco Medical Center
John Boehmer, MD
Role: PRINCIPAL_INVESTIGATOR
Milton S. Hershey Medical Center
Teresa De Marco, MD
Role: PRINCIPAL_INVESTIGATOR
University of California San Francisco Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Multiple locations
Saint Paul, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA, Boehmer JP, Higginbotham MB, De Marco T, Foster E, Yong PG. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol. 2003 Oct 15;42(8):1454-9. doi: 10.1016/s0735-1097(03)01042-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Clinicals0010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.